Form D · Biotechnology
ALSERES PHARMACEUTICALS INC /DE
Hopkinton, MA · CIK 0000094784
Offering snapshot reported Nov 10, 2009 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2009 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Aug 21, 2009 | Amendment | $3,900,000 | $2,900,000vs Apr 1, 2009 | 1 | SEC filing |
| Apr 1, 2009 | Initial | $1,000,000 | No comparison | Not reported | SEC filing |
| Mar 21, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-09478-4B
Source: Form D, filed Nov 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Henry Brem | Director |
| Gary E. Frashier | Director |
| William L.S. Guinness | Director |
| Robert Langer | Director |
| Michael J. Mullen | Director |
| John T. Preston | Director |
| Mark Pykett | Executive |
| Kenneth L. Rice, Jr. | Executive |
| Peter G. Savas | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
239 South Street
Hopkinton, MA, 01748
Hopkinton, MA, 01748